Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 27-Dec-23 4:10 PM View:  | Neurocrine Biosciences Inc. (NBIX) | 22-Dec-23 | Private Sale (Planned) | 10,000 | $130.04 | $1,300,440.00 | (5%) 203.7K to 193.7K | |
| 05-Dec-23 4:54 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Dec-23 | Option Exercise | 5,000 | $12.98 | $64,900.00 | 1% 412.39K to 417.39K | |
| 05-Dec-23 4:54 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Dec-23 | Planned Option Sale | 5,000 | $116.77 | $583,837.00 | (1%) 417.39K to 412.39K | |
| 14-Sep-23 4:51 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Sep-23 | Option Exercise | 5,000 | $12.98 | $64,900.00 | 1% 412.39K to 417.39K | |
| 14-Sep-23 4:51 PM View: | Neurocrine Biosciences Inc. (NBIX) | 12-Sep-23 | Planned Option Sale | 5,000 | $115.02 | $575,120.00 | (1%) 417.39K to 412.39K | |
| 06-Sep-23 4:25 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Sep-23 | Option Exercise | 5,000 | $12.98 | $64,900.00 | 1% 412.39K to 417.39K | |
| 06-Sep-23 4:25 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Sep-23 | Planned Option Sale | 5,000 | $110.06 | $550,316.00 | (1%) 417.39K to 412.39K | |
| 12-Jul-23 6:45 PM View: | Rigel Pharmaceuticals, Inc. (RIGL) | 26-May-23 | Grant | 25,000 | -- | -- | 50% 50.0K to 75.0K | |
| 19-May-23 4:05 PM View: | Travere Therapeutics, Inc. (TVTX) | 17-May-23 | Grant | 4,500 | -- | -- | 11% 40.0K to 44.5K | |
| 02-Nov-22 6:42 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Oct-22 | Option Exercise | 15,000 | $12.71 | $190,650.00 | 4% 422.39K to 437.39K | |
| 02-Nov-22 6:42 PM View: | Neurocrine Biosciences Inc. (NBIX) | 31-Oct-22 | Planned Option Sale | 15,000 | $114.76 | $1,721,400.00 | (3%) 437.39K to 422.39K | |
| 05-Oct-22 7:00 PM View: | Neurocrine Biosciences Inc. (NBIX) | 04-Oct-22 | Private Sale (Planned) | 5,000 | $110.54 | $552,711.00 | (2%) 208.7K to 203.7K | |
| 23-May-22 5:50 PM View: | Rigel Pharmaceuticals, Inc. (RIGL) | 20-May-22 | Grant | 25,000 | -- | -- | 100% 25.0K to 50.0K | |
| 12-May-22 8:24 PM View: | Travere Therapeutics, Inc. (TVTX) | 11-May-22 | Grant | 3,000 | -- | -- | 8% 37.0K to 40.0K | |
| 27-Apr-22 5:26 PM View: | Neurocrine Biosciences Inc. (NBIX) | 25-Apr-22 | Option Exercise | 15,000 | $6.66 | $99,900.00 | 3% 432.39K to 447.39K | |
| 27-Apr-22 5:26 PM View: | Neurocrine Biosciences Inc. (NBIX) | 25-Apr-22 | Planned Option Sale | 15,000 | $92.76 | $1,391,390.00 | (3%) 447.39K to 432.39K | |
| 12-Oct-21 6:34 PM View: | Neurocrine Biosciences Inc. (NBIX) | 07-Oct-21 | Market Sale (Planned) | 5,000 | $105.06 | $525,294.00 | (2%) 213.7K to 208.7K | 1% |
| 14-Jun-21 8:25 PM View: | Neurocrine Biosciences Inc. (NBIX) | 10-Jun-21 | Market Sale (Planned) | 10,000 | $100.27 | $1,002,740.00 | (4%) 223.7K to 213.7K | 2% |
| 21-May-21 8:50 PM View: | Rigel Pharmaceuticals, Inc. (RIGL) | 19-May-21 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 18-May-21 9:22 PM View: | Travere Therapeutics, Inc. (TVTX) | 14-May-21 | Grant | 3,000 | -- | -- | 9% 34.0K to 37.0K | |
| 27-Jan-21 9:53 PM View: | Neurocrine Biosciences Inc. (NBIX) | 26-Jan-21 | Market Sale (Planned) | 400 | $120.00 | $48,000.00 | (< 1%) 224.1K to 223.7K | 4% |
| 27-Jan-21 9:53 PM View: | Neurocrine Biosciences Inc. (NBIX) | 25-Jan-21 | Market Sale (Planned) | 1,600 | $120.03 | $192,047.00 | (< 1%) 225.7K to 224.1K | 4% |
| 05-Jan-21 6:32 PM View: | Vical Inc. (FRTX) | 31-Dec-20 | Payment of Exercise | 5,967 | $0.78 | $4,654.26 | (24%) 24.73K to 18.76K | (6%) |
| 17-Sep-20 5:06 PM View: | Vical Inc. (FRTX) | 15-Sep-20 | Grant | 11,934 | $0.81 | $9,666.54 | 93% 12.79K to 24.73K | (12%) |
| 02-Sep-20 4:22 PM View: | Vical Inc. (FRTX) | 31-Aug-20 | Payment of Exercise | 8,977 | $0.94 | $8,438.38 | (41%) 21.77K to 12.79K | 24% |
| 02-Sep-20 4:22 PM View: | Vical Inc. (FRTX) | 31-Aug-20 | Option Exercise | 692 | -- | -- | 3% 21.08K to 21.77K | |
| 04-Aug-20 5:09 PM View: | Vical Inc. (FRTX) | 31-Jul-20 | Payment of Exercise | 346 | $0.92 | $318.32 | (2%) 21.43K to 21.08K | 21% |
| 04-Aug-20 5:09 PM View: | Vical Inc. (FRTX) | 31-Jul-20 | Option Exercise | 692 | -- | -- | 3% 20.73K to 21.43K | |
| 02-Jul-20 2:01 PM View: | Vical Inc. (FRTX) | 30-Jun-20 | Payment of Exercise | 346 | $1.00 | $346.00 | (2%) 21.08K to 20.73K | 27% |
| 02-Jul-20 2:01 PM View: | Vical Inc. (FRTX) | 30-Jun-20 | Option Exercise | 691 | -- | -- | 3% 20.39K to 21.08K | |
| 05-Jun-20 5:28 PM View: | Vical Inc. (FRTX) | 03-Jun-20 | Grant | 17,261 | -- | -- | 552% 3.13K to 20.39K | |
| 05-Jun-20 5:28 PM View: | Vical Inc. (FRTX) | 31-May-20 | Payment of Exercise | 346 | $1.16 | $401.36 | (10%) 3.47K to 3.13K | 38% |
| 05-Jun-20 5:28 PM View: | Vical Inc. (FRTX) | 31-May-20 | Option Exercise | 692 | -- | -- | 25% 2.78K to 3.47K | |
| 19-May-20 8:00 PM View: | Travere Therapeutics, Inc. (TVTX) | 15-May-20 | Grant | 3,000 | -- | -- | 10% 31.0K to 34.0K | |
| 05-Jun-20 5:28 PM View: | Vical Inc. (FRTX) | 30-Apr-20 | Payment of Exercise | 346 | $1.20 | $415.20 | (11%) 3.13K to 2.78K | 39% |
| 05-Jun-20 5:28 PM View: | Vical Inc. (FRTX) | 30-Apr-20 | Option Exercise | 692 | -- | -- | 28% 2.44K to 3.13K | |
| 05-Jun-20 5:28 PM View: | Vical Inc. (FRTX) | 31-Mar-20 | Payment of Exercise | 346 | $1.19 | $411.74 | (12%) 2.78K to 2.44K | 38% |
| 05-Jun-20 5:28 PM View: | Vical Inc. (FRTX) | 31-Mar-20 | Option Exercise | 691 | -- | -- | 33% 2.09K to 2.78K | |
| 05-Jun-20 5:28 PM View: | Vical Inc. (FRTX) | 29-Feb-20 | Payment of Exercise | 346 | $2.93 | $1,013.78 | (14%) 2.44K to 2.09K | 75% |
| 05-Jun-20 5:28 PM View: | Vical Inc. (FRTX) | 29-Feb-20 | Option Exercise | 692 | -- | -- | 40% 1.75K to 2.44K | |
| 05-Jun-20 5:28 PM View: | Vical Inc. (FRTX) | 14-Feb-20 | Payment of Exercise | 1,746 | $1.16 | $2,025.36 | (50%) 3.49K to 1.75K | 37% |
| 05-Jun-20 5:28 PM View: | Vical Inc. (FRTX) | 14-Feb-20 | Option Exercise | 3,491 | -- | -- | 100% 0 to 3.49K | |
| 13-Nov-19 4:41 PM View: | Neurocrine Biosciences Inc. (NBIX) | 08-Nov-19 | Market Sale (Planned) | 5,000 | $110.00 | $550,000.00 | (2%) 230.7K to 225.7K | (5%) |
| 05-Nov-19 4:38 PM View: | Neurocrine Biosciences Inc. (NBIX) | 01-Nov-19 | Market Sale (Planned) | 5,000 | $100.22 | $501,104.00 | (2%) 235.7K to 230.7K | (15%) |
| 31-Jul-19 7:15 PM View: | Neurocrine Biosciences Inc. (NBIX) | 30-Jul-19 | Market Sale (Planned) | 10,000 | $92.07 | $920,686.00 | (4%) 245.7K to 235.7K | (26%) |
| 10-May-19 8:36 PM View: | Travere Therapeutics, Inc. (TVTX) | 08-May-19 | Grant | 2,000 | -- | -- | 7% 29.0K to 31.0K | |
| 05-Nov-18 4:11 PM View: | Neurocrine Biosciences Inc. (NBIX) | 02-Nov-18 | Market Sale (Planned) | 15,000 | $114.41 | $1,716,210.00 | (6%) 260.7K to 245.7K | (1%) |
| 15-Jun-18 4:45 PM View: | Neurocrine Biosciences Inc. (NBIX) | 13-Jun-18 | Market Sale (Planned) | 15,000 | $99.24 | $1,488,550.00 | (5%) 275.7K to 260.7K | (16%) |
| 11-May-18 9:07 PM View: | Travere Therapeutics, Inc. (TVTX) | 09-May-18 | Grant | 2,500 | -- | -- | 9% 26.5K to 29.0K | |
| 05-Apr-18 6:52 PM View: | Neurocrine Biosciences Inc. (NBIX) | 03-Apr-18 | Payment of Exercise | 1,369 | $77.23 | $105,728.00 | (< 1%) 277.07K to 275.7K | (50%) |